Champix Effective in Helping Smokers Kick the Habit in UK

by Gopalan on August 22, 2008 at 9:05 AM
 Champix Effective in Helping Smokers Kick the Habit in UK

The controversial Champix has indeed been effective in helping smokers kick the habit in the UK, data gathered by the National Health Service reveal.

One in seven people trying to quit are using Champix, according to the first figures published since the stop smoking drug was licensed in 2006.


And NHS Information Centre figures showed 63% of people were successful last year at the four-week mark compared to half using nicotine replacement therapy.

Champix has come under scrutiny over reports it causes suicidal feelings, but no one seems to have actually gone on to commit suicide.

The Medicines and Healthcare Products Regulatory Agency says it is "closely" monitoring the drug after almost 3,000 reports of adverse reactions.

And there have been more than 200 reports of suicidal thoughts in patients taking Champix.

Besides 350 cases of depression have also been reported, although these have mainly involved patients who had an underlying psychiatric illness.

The drug is unusual as it both stimulates and blocks specific nicotinic receptors in the brain.

By stimulating the receptor it is thought to mimic the effects of nicotine to reduce cravings.

At the same time, it partially blocks the receptor preventing nicotine from binding to it, resulting in a weaker response in people who give in to temptation and have a cigarette.

Trials suggested around 44% of smokers give up after taking the drug twice a day for 12 weeks, compared with 18% of those given a placebo and 30% of those taking another major anti-smoking drug, bupropion.

The latest figures show that in 2007-8 - the first year since the smoking ban was introduced - there was a 13% increase to 680,000 in the number of people setting a quit date.

There was also a 10% rise to 350,800 in the number of people who had stuck to their attempts to quit after four weeks.

NHS Stop Smoking Services spent almost 61 million in the past year on helping people to quit - nearly 10 million higher than the year before.

Health minister Ann Keen said she was delighted with the increase in people successfully quitting smoking, BBC reports.

"I'd like to take this opportunity to say congratulations to all those who have made such positive efforts to kick the habit - very well done.

"This shows that the investments that we are making in helping smokers to quit are having a positive impact."

Source: Medindia
Font : A-A+



Recommended Readings

Latest Respiratory Disease News

Annual Flu Vaccine: Crucial in Preventing Severe Flu Complications
Over 1 in 4 high-risk US adults (28%) not planning flu vaccination despite susceptibility to complications.
China Pneumonia Outbreak Not Linked to New Virus
The ongoing pneumonia outbreak impacting young children in China is not linked to a newly identified virus.
Pneumonia Vaccine Found Effective in Macaques
A recently developed pneumococcal vaccination was proven to be successful in the trials involving macaque monkeys.
AI-aided Home Stethoscope Monitors Asthma
Using the auscultatory sounds of asthmatic kids under age five, StethoMe, an AI-based home stethoscope, was able to accurately diagnose asthma exacerbation.
Indian Doctors Urge Heightened Surveillance Amid China's Pneumonia Cases
Given the recent series of pneumonia cases in China, Indian doctors are recommending increased vigilance and enhanced hygiene practices.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Champix Effective in Helping Smokers Kick the Habit in UK Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests